Six states are part of a pilot program by CMS to reduce “waste, fraud and abuse.” ...
Centers for Medicare & Medicaid Services said on Wednesday it has extended key application ‌deadlines for drugmakers and ...
The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 drugs for obesity in Medicare.
The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...
The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...
In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...
The Legislative Budget Commission on Tuesday approved two requests from the Agency for Health Care Administration to give it ...
The Trump administration will require all 50 states to explain their plans to revalidate some of their Medicaid providers in ...
A Senate-passed proposal to restore access to GLP-1 medications for weight loss for adults on the Medicaid program got a big thumbs down from a critical House committee Wednesday. Without debate, the ...